Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients
Clinical trial NCT04732455 · COMPLETED
Trial details
- NCT number
- NCT04732455
- Sponsor
- Gamal Mohamed Taha Abouelmagd
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2022-06-08
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.